Shuttle Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Shuttle Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SHPH | Shuttle Pharmaceuticals | -$39.75 | — | — | — | $0.00 | — | — | — | 11/12/2025 | |
SHPH | Shuttle Pharmaceuticals | -$24.12 | — | -$3.29 | — | $0.00 | — | $0.00 | — | 08/13/2025 | |
SHPH | Shuttle Pharmaceuticals | -$20.75 | — | -$7.50 | — | $0.00 | — | $0.00 | — | 05/08/2025 | |
SHPH | Shuttle Pharmaceuticals | -$22.00 | — | $3.75 | — | $0.00 | — | $0.00 | — | 02/26/2025 | |
SHPH | Shuttle Pharmaceuticals | -$22.75 | — | -$39.75 | — | $0.00 | — | $0.00 | — | 11/13/2024 | |
SHPH | Shuttle Pharmaceuticals | -$30.75 | — | -$24.00 | — | $0.00 | — | $0.00 | — | 09/04/2024 | |
SHPH | Shuttle Pharmaceuticals | -$14.00 | — | -$20.00 | — | $0.00 | — | $0.00 | — | 05/13/2024 | |
SHPH | Shuttle Pharmaceuticals | -$12.00 | — | -$22.00 | — | $0.00 | — | $0.00 | — | 03/21/2024 | |
SHPH | Shuttle Pharmaceuticals | -$20.00 | — | -$22.00 | — | $0.00 | — | $0.00 | — | 11/14/2023 | |
SHPH | Shuttle Pharmaceuticals | — | — | -$30.00 | — | — | — | $0.00 | — | 08/14/2023 | |
SHPH | Shuttle Pharmaceuticals | -$0.56 | — | -$14.00 | — | — | — | $0.00 | — | 05/25/2023 | |
SHPH | Shuttle Pharmaceuticals | — | — | -$12.00 | — | — | — | $0.00 | — | 03/15/2023 | |
SHPH | Shuttle Pharmaceuticals | — | — | -$20.00 | — | — | — | $0.00 | — | 11/14/2022 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Shuttle Pharmaceuticals (SHPH) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2025 per il Q2.
L'EPS effettivo era $-3.29, che mancato la stima di $0.00.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.